<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Oxford Chemistry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/84EC36D9-AAC8-496A-B69B-F9DE2213B154"><gtr:id>84EC36D9-AAC8-496A-B69B-F9DE2213B154</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6067F726-BE74-4EDA-AFAE-A87C2F294986"><gtr:id>6067F726-BE74-4EDA-AFAE-A87C2F294986</gtr:id><gtr:firstName>Darren</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Dixon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG007802%2F1"><gtr:id>A3383AA2-8775-47B7-AB7F-5AC37DD7879C</gtr:id><gtr:title>New Synthesis-Enabling Reactions and Reaction Cascades for the Discovery and Production of Potential Anti-Cancer Compounds</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>EP/G007802/1</gtr:grantReference><gtr:abstractText>Alongside the surgeon's knife and radiotherapy, chemotherapy is one of the most effective weapons especially on inoperable and aggressive cancers such as small cell lung cancer. To date there are still many more cancers than effective medicines and there remains the need for effective anti-cancer treatments that are both selective and potent. The majority of the existing drugs in clinical use are of natural origin or are man made analogues of these natural products. These (often) cytotoxic natural products are employed by the host organism as a means of self-defense and over millennia have evolved to be both potent and selective in their modes of action against predators. An excellent example is paclitaxel [taxol] first isolated from the pacific yew tree and currently used in the treatment of lung, ovarian and breast cancers. If the natural product can be harvested on scale and in a sustainable fashion, or be created by fermentation techniques in the laboratory, then an effective marketable drug can be developed. When this is not possible the only remaining option is to manufacture through the process of chemical synthesis. However, these target molecules often possess such complex three dimensional structures that the traditional, one-step, one-pot chemical synthesis approaches become so lengthy that only milligram quantities can be obtained. This problem maybe overcome by the strategic implementation of new synthesis enabling reactions and reaction cascades into chemical routes from appropriate and readily available starting materials. These can allow the construction of the complex target molecules in around 15 steps, compared with 30-40 steps using traditional approaches. Accessing complex molecules in around 15 steps means that these molecules (and libraries of analogues) may now be made at speed and possibly on gram scale. In addition, large quantities of late stage intermediates resembling in part the natural product can be accessed and converted into libraries of structurally simplified natural product analogues. Such synthesis capability may allow thorough biological evaluation for the first time and the creation of powerful structure / activity relationships that can be fed back into the synthesis cycle, potentially resulting in compounds with enhanced biological activity, and eventually lead to attractive drug candidates. Our group has been engaged over the past 3 years in the discovery and development of new asymmetric catalysts, new powerful catalyst-enabled synthetic methodology and most relevant to this proposal, new catalyst and multi-catalyst enabled reaction cascade sequences. Reaction cascades are powerful in synthesis as they allow a series of bond-forming reactions to occur in a single vessel / thus building complexity and maximizing efficiency. By judicious choice of starting materials and catalysts, advanced intermediates can be created in one efficient operation. During the five year Fellowship we wish to significantly expand the lines of research opened up by these preliminary studies, develop new catalyst enabled synthetic methodology and reaction cascades, and apply the findings to the total synthesis of a number of complex bioactive alkaloid natural products. For the first three years of the fellowship we wish to develop new chemistry and strategies leading to the short and effective stereoselective total synthesis of both daphniyunnine D and manzamine A (and their analogues for biological evaluation and the development of SAR).</gtr:abstractText><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1336583</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>This present invention relates to bifunctional organocatalysts containing a basic functional group and hydrogen bond donor. In particular, the invention relates to bifunctional organocatalysts comprising a basic iminophosphorane group and a hydrogen bond donor group. The invention also provides chemical reactions catalysed by the bifunctional organocatalysts of the invention. Also provided are synthetic precursors of the bifunctional organocatalysts and methods of synthesising the bifunctional organocatalysts.
The use of organic molecules to catalyse chemical transformations is well-known in the art. Nucleophilic catalysts such as 4-dimethylaminopyridine (DMAP), 1,4-diazabicyclo[2.2.2]octane (DABCO) and quinuclidine are widely used as catalysts for the formation of esters and for Baylis-Hillman reactions. Proline and derivatives thereof have been used as chiral catalysts, notably for asymmetric aldol reactions, although high catalyst loadings are often required.
In recent years, a number of bifunctional organocatalysts have been reported. In particular, a number of organocatalysts are known which contain both basic and hydrogen bond donor functionality. These combine the capacity to activate and organise electrophilic substrates via hydrogen bonding with the activation of pro-nucleophilic reagents via deprotonation. Where the bifunctional catalysts are chiral, catalysed reactions may proceed with high levels of stereocontrol.
Among the most successful bifunctional organocatalysts of this type are those derived from cinchona alkaloids, such as I (Deng et al., Journal of the American Chemical Society 2004, volume 126, pages 9906 - 9907), II (Hiemstra et al., Angewandte Chemie International Edition, 2006, volume 45, pages 929 - 931) and III (Connon et al., Angewandte Chemie International Edition 2005, volume 44, pages 6367 - 6370; Dixon et al., Chemical Communications, 2005, pages 4481 - 4483; S?os et al., Organic Letters, 2005, volume 7, pages 1967 - 1969; Chen et al., Synlett, 2005, pages 603 - 606), and the cyclohexane-1,2-diamine derivatives IV (Takemoto et al., Journal of the American Chemical Society 2003, volume 125, pages 12672 - 12673) and V (Berkessel et al., Chemical Communications, 2005, pages 1898 - 1900). However, despite the surge of interest in this field in the last decade, reaction rates are often low, high catalyst loadings are often required, and the range of compatible pro-nucleophiles and electrophilic substrates is limited Accordingly, there remains a need in the art for new bifunctional organocatalysts which provide enhanced reactivity compared to those currently available in the art. In particular, there is a need in the art for new chiral bifunctional organocatalysts which provide both enhanced activity and high levels of stereocontrol. Preferably, such enhanced reactivity would be obtainable even with low catalyst loadings. In addition, such bifunctional organocatalysts would preferably be amenable to library generation so as to facilitate optimisation procedures.
The present invention is based at least in part on a realisation that an inherent restriction of existing bifunctional organocatalysts is the fixed nature of the basic functionality. The present inventors have recognised that low-acidity pro-nucleophiles and/or low energy electrophiles often do not react at all in the presence of existing bifunctional organocatalysts owing to negligible activation of the pro-nucleophile by the weak basic functionality. Furthermore, adaptation of existing systems to address this defect is not readily achievable. Cinchona alkaloids-derived catalysts such as I, II and III, are dependent on the availability of precursors from the chiral pool and no modification of the basic bridgehead nitrogen atom is possible. In systems such as IV and V, the size of the tertiary amine group may be varied by changing the alkyl substituents on the nitrogen atom. However, this has minimum effect on the pKa basicity of this group. Furthermore, in these systems, the incorporation of the N,N-dialkylamine groups occurs early in the synthesis, thereby making library generation laborious since there is no late-stage branch point in the synthesis to install alternative tertiary amines. Accordingly, the present invention provides new bifunctional organocatalysts which aim to address one or more of these deficiencies of existing systems.</gtr:description><gtr:grantRef>EP/G007802/1</gtr:grantRef><gtr:id>6CA00D7D-6E88-4394-BE57-8985B0EE2305</gtr:id><gtr:impact>Currently catalysts are on sale at Fluorochem</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c803761d9da7.33134372</gtr:outcomeId><gtr:patentId>WO/2014/064466.</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>&amp;quot;Bifunctional Organic Catalysts&amp;quot;</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>New chemical cascade processes to complex and desirable molecular scaffolds were developed using spatially defined multifuncational catalysts as the key stereochemical controller in carbon-carbon bond forming steps. These new catalysed processes will find general use in the pharmaceutical and fine chemicals sectors. Put together these processes allowed us to define the first genuinely short and effective route to complex marine anticancer products nakadomarin A, manzamine A and the core scaffolds of various daphniphyllum alkaloids. Thus the arising methods and processes will find use in both academic and industrial contexts and the late stage products coud find use as leads in both biology and medicine.</gtr:description><gtr:exploitationPathways>The catalysts and methodologies that were developed as part of this project were particularly effective at constructing functionally dense, stereochemically defined scaffolds in single pot procedures. As such they will find use in both library synthesis and target synthesis in industry. The construction of chiral products in single enantiomeric form is industrially relevant. Having generated new and effective routes to bioactive natural products, the creation of molecular probes based on these chemistries is made particularly simple. This work is currently in progress with the aim of identifying the cellular targets of manzamine A and its relatives.



Identifying new and effective routes to functionally dense, stereochemically defined scaffolds in single pot procedures will allow pharmaceutical companies to design new lead scaffolds on the back of this chemistry.</gtr:exploitationPathways><gtr:id>81D4B3CE-7D64-4217-BA57-6264E32BDCA7</gtr:id><gtr:outcomeId>r-420915522.07331693774fc7ae</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.organic-chemistry.org/Highlights/2013/06May.shtm</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D0A74DF5-244B-4A41-897A-5054F6171875</gtr:id><gtr:title>Acid-catalyzed synthesis of bicyclo[3.n.1]alkenediones.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f65504e04bdd90043a7c33a3ae5cc11a"><gtr:id>f65504e04bdd90043a7c33a3ae5cc11a</gtr:id><gtr:otherNames>Michaelides IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01b01bfa86338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C729A81-8BF9-4820-8B42-2ECA2787BEF5</gtr:id><gtr:title>One-Pot Asymmetric Nitro-Mannich/Hydroamination Cascades for the Synthesis of Pyrrolidine Derivatives: Combining Organocatalysis and Gold Catalysis.</gtr:title><gtr:parentPublicationTitle>ACS catalysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b406ec5fc4ae443b9d2b6c89729f0bc"><gtr:id>0b406ec5fc4ae443b9d2b6c89729f0bc</gtr:id><gtr:otherNames>Barber DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56cb960e3be6a8.01209180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC437DF2-D612-4D31-8023-1BE41522C916</gtr:id><gtr:title>Design, synthesis and applications of new families of chiral sulfonic acids</gtr:title><gtr:parentPublicationTitle>Tetrahedron: Asymmetry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0392b05bb4fb0cf03617f65eb0bf271c"><gtr:id>0392b05bb4fb0cf03617f65eb0bf271c</gtr:id><gtr:otherNames>Jakubec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cb960c9bc1a2.62629266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2831E7F2-E717-4790-92B7-97B3EBD5CA1E</gtr:id><gtr:title>Diastereodivergent organocatalytic asymmetric vinylogous Michael reactions.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93f8556619f3487d06c35513ec7d86fb"><gtr:id>93f8556619f3487d06c35513ec7d86fb</gtr:id><gtr:otherNames>Li X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56cb960d7fd8c8.54329540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FB80A58-E146-4155-A27A-89AAA194448A</gtr:id><gtr:title>Organocatalytic Ring-Opening Polymerization of Cyclic Esters Mediated by Highly Active Bifunctional Iminophosphorane Catalysts</gtr:title><gtr:parentPublicationTitle>Macromolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590a95d65352a93316abdc87deb97c67"><gtr:id>590a95d65352a93316abdc87deb97c67</gtr:id><gtr:otherNames>Goldys A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56cb960e07d653.88014911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F6A4692-E009-47DF-81AC-CF70166D814D</gtr:id><gtr:title>Direct catalytic enantio- and diastereoselective ketone aldol reactions of isocyanoacetates.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05576fae58bfc0c010ed58d1c05e4f94"><gtr:id>05576fae58bfc0c010ed58d1c05e4f94</gtr:id><gtr:otherNames>de la Campa R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56cb960ccc1ee4.98861518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1EB478E-A3DC-4140-B1E3-9FA188C5045E</gtr:id><gtr:title>Gold and BINOL-phosphoric acid catalyzed enantioselective hydroamination/N-sulfonyliminium cyclization cascade.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e0b7f6bdcc49fa4fe9f96e69c03866"><gtr:id>08e0b7f6bdcc49fa4fe9f96e69c03866</gtr:id><gtr:otherNames>Gregory AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>5463b5d036a442.41540061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA5B3FA4-B03F-412E-872E-A723D203CED3</gtr:id><gtr:title>Total Synthesis of (-)-Himalensine A.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2c27e62e42f495e188725f3e1be5c4"><gtr:id>9a2c27e62e42f495e188725f3e1be5c4</gtr:id><gtr:otherNames>Shi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>5aaa4e5543dc40.94381541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE312CEC-3CAA-4C38-93F6-4F40B9CF7D16</gtr:id><gtr:title>Towards the total synthesis of keramaphidin B.</gtr:title><gtr:parentPublicationTitle>Beilstein journal of organic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0392b05bb4fb0cf03617f65eb0bf271c"><gtr:id>0392b05bb4fb0cf03617f65eb0bf271c</gtr:id><gtr:otherNames>Jakubec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1860-5397</gtr:issn><gtr:outcomeId>58c7e81611bbd5.72744141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E91B6486-E9CB-4A14-8510-6116D5685956</gtr:id><gtr:title>Expedient Route to the functionalized calyciphylline A-type skeleton via a Michael addition-RCM strategy.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9374652352356283dfe19fe7fe55da8f"><gtr:id>9374652352356283dfe19fe7fe55da8f</gtr:id><gtr:otherNames>Sladojevich F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c01dfeaa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD0CEC27-21BE-4C50-BA82-CAAD83667596</gtr:id><gtr:title>Synthesis of macrocyclic natural products by catalyst-controlled stereoselective ring-closing metathesis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a0029150620f65feff65f8b10d27745"><gtr:id>6a0029150620f65feff65f8b10d27745</gtr:id><gtr:otherNames>Yu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>doi_53d0260268413a19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D0D6767-73C3-4D05-A1D0-44E73EA8CB45</gtr:id><gtr:title>Stereoselective, nitro-Mannich/lactamisation cascades for the direct synthesis of heavily decorated 5-nitropiperidin-2-ones and related heterocycles.</gtr:title><gtr:parentPublicationTitle>Beilstein journal of organic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0392b05bb4fb0cf03617f65eb0bf271c"><gtr:id>0392b05bb4fb0cf03617f65eb0bf271c</gtr:id><gtr:otherNames>Jakubec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1860-5397</gtr:issn><gtr:outcomeId>doi_53d08808839a6003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D91E802-53D5-437A-8C05-6BBBF8CA49A6</gtr:id><gtr:title>Total synthesis of (-)-nakadomarin A.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe040786dcf119105099b35ba45100b"><gtr:id>fbe040786dcf119105099b35ba45100b</gtr:id><gtr:otherNames>Kyle AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>doi_53d02d02dd6f2cc2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5CF893B-A0D3-4B37-A757-7B6370B36956</gtr:id><gtr:title>Br&amp;oslash;nsted base/Lewis acid cooperative catalysis in the enantioselective Conia-ene reaction.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c370180d83fb3dc0153c046b4566a2b2"><gtr:id>c370180d83fb3dc0153c046b4566a2b2</gtr:id><gtr:otherNames>Yang T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>doi_53d0180181502ae2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B99DC4AC-5D19-4DFB-AEC2-367481A2CB80</gtr:id><gtr:title>Enantio- and diastereoselective Michael additions of C-succinimidyl esters to nitro olefins using cinchonine-derived bifunctional organocatalysts</gtr:title><gtr:parentPublicationTitle>Tetrahedron: Asymmetry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0392b05bb4fb0cf03617f65eb0bf271c"><gtr:id>0392b05bb4fb0cf03617f65eb0bf271c</gtr:id><gtr:otherNames>Jakubec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>doi_53d00d00d00edffc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5EA0F36-FE9F-4CC2-982D-26F08F04EB6E</gtr:id><gtr:title>Strategies towards the synthesis of calyciphylline A-type Daphniphyllum alkaloids.</gtr:title><gtr:parentPublicationTitle>Natural product reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d06e2dde6b27cc9f8c9b69bb703dfa"><gtr:id>95d06e2dde6b27cc9f8c9b69bb703dfa</gtr:id><gtr:otherNames>Kang B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0265-0568</gtr:issn><gtr:outcomeId>5463b58ac264a4.76336311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4CCD5F1-3CE2-4E76-96A0-DBC61C719E98</gtr:id><gtr:title>Direct catalytic enantio- and diastereoselective Mannich reaction of isocyanoacetates and ketimines.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38b5d035170cccc48ee4cbcf581ff26f"><gtr:id>38b5d035170cccc48ee4cbcf581ff26f</gtr:id><gtr:otherNames>Ort?n I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56cb960da4c033.62511081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52577C4F-ACEB-4791-AAEA-9BDD0A904A05</gtr:id><gtr:title>An expedient stereoselective route to the ACE tricyclic core of manzamine A via a palladium-catalysed arylative allene spirocyclisation cascade</gtr:title><gtr:parentPublicationTitle>Tetrahedron Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a424e78b67219fa6bb113e3ebe84cb5"><gtr:id>0a424e78b67219fa6bb113e3ebe84cb5</gtr:id><gtr:otherNames>Hawkins A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_53d00d00d457d504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77532093-C524-4009-B650-79266E09EDB0</gtr:id><gtr:title>a-Alkylation of ketimines using visible light photoredox catalysis</gtr:title><gtr:parentPublicationTitle>RSC Advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a379666b00e4cf091a2f1a7ad2e99842"><gtr:id>a379666b00e4cf091a2f1a7ad2e99842</gtr:id><gtr:otherNames>Franchino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a6f57d66f3414.21883430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5B8AC38-944F-4C13-9FF2-C3623B529E46</gtr:id><gtr:title>Bifunctional iminophosphorane organocatalysts for enantioselective synthesis: application to the ketimine nitro-Mannich reaction.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a639fcd8607a6a005bae6d649e2eaa9c"><gtr:id>a639fcd8607a6a005bae6d649e2eaa9c</gtr:id><gtr:otherNames>N??ez MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>56cb960e6f07a4.93983460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A82E4C3B-A2DC-4D56-BFA7-6A48C7A81BF3</gtr:id><gtr:title>Enantioselective desymmetrization of prochiral cyclohexanones by organocatalytic intramolecular Michael additions to a,?-unsaturated esters.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcfdff3c6e65ffd3b89175891c009d89"><gtr:id>fcfdff3c6e65ffd3b89175891c009d89</gtr:id><gtr:otherNames>Gammack Yamagata AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56cb960d042113.63624053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DB85361-CDDF-412B-84DA-599751DB9235</gtr:id><gtr:title>Iridium-catalyzed reductive nitro-Mannich cyclization.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e0b7f6bdcc49fa4fe9f96e69c03866"><gtr:id>08e0b7f6bdcc49fa4fe9f96e69c03866</gtr:id><gtr:otherNames>Gregory AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>56cb960d32b958.34611016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99CBDC91-9E1F-4D40-9FB8-5EF7E2B21656</gtr:id><gtr:title>Facile multi-decagram synthesis of methyl but-2-ynoate</gtr:title><gtr:parentPublicationTitle>Organic Chemistry Frontiers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/203a293dd54175a49a5d1ece607e9e44"><gtr:id>203a293dd54175a49a5d1ece607e9e44</gtr:id><gtr:otherNames>Darses B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56cb960dd181a1.54012564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79EA6899-BB80-4542-912A-64D3E2A39788</gtr:id><gtr:title>Total synthesis of (-)-nakadomarin A: alkyne ring-closing metathesis</gtr:title><gtr:parentPublicationTitle>Tetrahedron Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0392b05bb4fb0cf03617f65eb0bf271c"><gtr:id>0392b05bb4fb0cf03617f65eb0bf271c</gtr:id><gtr:otherNames>Jakubec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>doi_53d00d00d444f29d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E755206B-6CBD-4B40-ADA8-77FA0E06969F</gtr:id><gtr:title>Alkali base-initiated Michael addition/alkyne carbocyclization cascades.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2963be2453c59fbe3e028688a46918"><gtr:id>aa2963be2453c59fbe3e028688a46918</gtr:id><gtr:otherNames>Kourra C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c070688d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B60E1640-8E77-49A2-8DE8-681EADD79D4C</gtr:id><gtr:title>Total synthesis of manzamine A and related alkaloids.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0392b05bb4fb0cf03617f65eb0bf271c"><gtr:id>0392b05bb4fb0cf03617f65eb0bf271c</gtr:id><gtr:otherNames>Jakubec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>doi_53d017017ba6614d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D455D639-856F-4D59-ADF7-340F82BD8440</gtr:id><gtr:title>Total synthesis of (-)-nakadomarin A.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0392b05bb4fb0cf03617f65eb0bf271c"><gtr:id>0392b05bb4fb0cf03617f65eb0bf271c</gtr:id><gtr:otherNames>Jakubec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>doi_53d01801842673a4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C05F925-BA99-434F-9101-803366A13F3B</gtr:id><gtr:title>Creation through immobilization: a new family of high performance heterogeneous bifunctional iminophosphorane (BIMP) superbase organocatalysts.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bb44edd6209e956180b44b789c1945c"><gtr:id>2bb44edd6209e956180b44b789c1945c</gtr:id><gtr:otherNames>Goldys AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>56cb960d5c2ec1.98207858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7ADD6AF-8B6B-4345-8DDC-706A2DCD7361</gtr:id><gtr:title>Efficient and selective formation of macrocyclic disubstituted Z alkenes by ring-closing metathesis (RCM) reactions catalyzed by Mo- or W-based monoaryloxide pyrrolide (MAP) complexes: applications to total syntheses of epilachnene, yuzu lactone, ambrettolide, epothilone C, and nakadomarin A.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55e9c812cfbba94f1e7e00b693cdb8e1"><gtr:id>55e9c812cfbba94f1e7e00b693cdb8e1</gtr:id><gtr:otherNames>Wang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc3fc32c25b5a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A6C75E6-646A-4F7C-820D-D06EA8A35176</gtr:id><gtr:title>Expedient construction of the [7-5-5] all-carbon tricyclic core of the Daphniphyllum alkaloids daphnilongeranin B and daphniyunnine D.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/203a293dd54175a49a5d1ece607e9e44"><gtr:id>203a293dd54175a49a5d1ece607e9e44</gtr:id><gtr:otherNames>Darses B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c095c4e9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CB2CCFF-794A-475A-A048-506190333EEA</gtr:id><gtr:title>Enantioselective synthesis of (-)-chloramphenicol via silver-catalysed asymmetric isocyanoacetate aldol reaction.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a379666b00e4cf091a2f1a7ad2e99842"><gtr:id>a379666b00e4cf091a2f1a7ad2e99842</gtr:id><gtr:otherNames>Franchino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>56cb960c65d388.78402274</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G007802/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>B30DC286-3309-48E2-A15D-BDF547057A33</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Drug Formulation &amp; Delivery</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>